ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$243.91
Tradestie Score
54
Market Cap
$12.36B
P/E Ratio
29.2
Revenue Growth
1.4%
Analyst Upside
+26.2%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$28.87
|
$19.56B | 21.7 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$119.52
|
$16.93B | 16.2 | 59 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.43
|
$15.70B | 31.2 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.02
|
$15.22B | - | 57 | Compare |
|
EXEL
Exelixis Inc
|
$53.03
|
$11.09B | 18.5 | 47 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.91
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$54.82
|
$10.74B | - | 51 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$60.02
|
$10.53B | 43.6 | 53 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$51.77
|
$10.49B | - | 59 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$80.09
|
$10.22B | - | 56 | Compare |
More ASND Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry